Iron, TIBC, and Transferrin Saturation by Decade of Life: What the Numbers Actually Mean
Serum iron, total iron-binding capacity (TIBC), and transferrin saturation (TSAT, calculated as serum iron divided by TIBC, multiplied by 100) are a package. Reading any one of them without the other two, and without ferritin and a marker of inflammation such as C-reactive protein (CRP), routinely produces the wrong conclusion. The useful question for a given lab report is not "is this number normal" but "what decade of life, sex, and inflammatory state is this number sitting inside," because the same TSAT of 18% means something different in a 15-year-old menstruating girl than in a 70-year-old man on a proton pump inhibitor.
This article is an interpretive guide, not a diagnostic tool. It does not replace an evaluation by a clinician who can order ferritin, CRP, a complete blood count, and, when indicated, HFE genetic testing or endoscopy.
How the three markers relate, in one paragraph
Serum iron measures iron currently bound to transferrin in the blood and swings with meals, time of day, and acute illness, so it is drawn fasting. TIBC estimates how much iron transferrin could carry if fully saturated; the liver makes more transferrin (raising TIBC) when iron stores are low, and less (lowering TIBC) when iron is abundant or when inflammation suppresses transferrin synthesis. TSAT, the ratio of the two, is the most direct single indicator of hemochromatosis risk when persistently elevated, and a low TSAT combined with a low ferritin is the most direct pattern for iron deficiency; a low TSAT with a high or normal ferritin more often reflects inflammation than true iron lack, which is why ferritin and CRP have to be interpreted together with the iron panel rather than in place of it.
Reference ranges versus optimal ranges
Lab reference intervals describe where roughly 95% of a reference population fell when the assay was validated, not where a given person should aim to be. A commonly used adult range is serum iron of about 60 to 170 mcg/dL, TIBC of about 250 to 370 mcg/dL, and TSAT of about 20 to 45%, though exact cutoffs vary by laboratory and assay. Values in the lower quarter of "normal" can still represent early iron depletion in someone with fatigue or reduced exercise tolerance, and values in the upper quarter of "normal" are not automatically benign in a person with a family history of hemochromatosis. Treat the printed range as a starting boundary, not a verdict.
Iron status through childhood (roughly ages 0 to 10)
Growth and expanding red cell mass make early childhood a period of high iron demand relative to body size. The Centers for Disease Control and Prevention has long recommended screening hemoglobin around 9 to 12 months of age and targeted iron-status screening in children with risk factors such as low income, prematurity, or exclusive breastfeeding beyond 6 months without iron-fortified foods (CDC, 1998 MMWR recommendations; this guidance is dated and pediatric practice should be checked against current AAP and CDC statements before acting on it).
Infants and toddlers run lower serum iron and somewhat higher TIBC than adults, and a low TSAT together with a low MCV and low ferritin in a toddler is a reasonable trigger for further evaluation and dietary counseling. Specific prevalence figures for iron deficiency in US toddlers by subgroup exist in the pediatric literature, but the exact percentages circulating online vary by survey year and definition; a precise number should not be quoted without checking the current NHANES-based estimate against the primary publication.
Adolescence (roughly ages 11 to 19)
Menstruation adds a recurring iron loss that most boys never experience, which is the main reason iron deficiency is more common in teenage girls than in almost any other demographic group besides pregnant women. TIBC in menstruating teens often runs at the high end of normal or mildly above it, and a low TSAT with a low ferritin in this group is usually straightforward to interpret and treat with dietary counseling or supplementation once other causes of fatigue are considered.
Endurance athletes, especially runners, are a separate risk group. Repetitive foot-strike causes low-grade intravascular hemolysis, and heavy training also raises hepcidin, which blocks iron absorption; this combination lowers serum iron and TSAT independent of diet in some athletes (NIH Office of Dietary Supplements iron fact sheet discusses absorption physiology generally). Exact prevalence figures for iron deficiency in female athletes vary considerably across studies and should be treated as approximate.
Reproductive-age adults (roughly ages 20 to 39)
Menstruating women need substantially more dietary iron than men of the same age because of ongoing blood loss; the NIH Office of Dietary Supplements lists the recommended dietary allowance for iron as 18 mg/day for women aged 19 to 50 and 8 mg/day for men in the same age range (NIH ODS Iron Fact Sheet for Health Professionals). A TSAT in roughly the 20 to 35% range is generally considered adequate in this group, though what counts as "optimal" rather than merely "not deficient" is a matter of ongoing debate among clinicians who focus on fatigue and performance rather than anemia alone; this optimal-range framing is a clinical opinion, not an established guideline threshold, and should be presented to patients as such.
Men in their 20s and 30s rarely become iron deficient from diet alone. A TSAT that runs persistently above roughly 40 to 45% in a young man without an obvious explanation (recent transfusion, non-fasting draw, acute liver injury) is one of the reasons hereditary hemochromatosis screening exists at this age, since HFE-related iron loading can begin producing detectable biochemical changes before symptoms appear.
Midlife (roughly ages 40 to 59)
As menstrual cycles become irregular through perimenopause and then stop, the chronic iron loss that shaped a woman's iron status for two to three decades disappears, and ferritin and TSAT typically drift upward over subsequent years. This is expected physiology in most women and is not itself a sign of overload. A TSAT that climbs into a clearly elevated range (commonly cited thresholds are above 45%) together with a rising ferritin still deserves attention, because a meaningful fraction of women with HFE C282Y homozygosity are not identified until after menopause removes the protective effect of menstrual losses.
This is also the decade in which chronic conditions such as type 2 diabetes, chronic kidney disease, and inflammatory bowel disease become more common, and these conditions can produce a pattern that mimics iron deficiency: low serum iron and low TSAT with an elevated or inappropriately normal ferritin, driven by inflammation rather than by empty iron stores. The distinguishing clue is usually TIBC: it tends to be low or low-normal in inflammatory states and elevated in true iron deficiency. When the picture is genuinely ambiguous, soluble transferrin receptor testing can help separate the two, though this is a specialized test that is not always necessary.
Men in this decade are the group in whom HFE-related hemochromatosis most often becomes clinically apparent, because men accumulate iron faster than premenopausal women across their whole adult life and organ effects (liver fibrosis, diabetes, cardiomyopathy, hypogonadism) tend to surface once total body iron has been elevated for years. Exact figures for what fraction of C282Y homozygotes develop overt organ damage by a given age vary across cohort studies and should be checked against a current hepatology guideline rather than quoted from memory.
Older adults (roughly ages 60 to 79)
Serum iron and TSAT decline modestly with healthy aging. A TSAT in the high teens to low twenties in an older adult with a normal ferritin, a normal MCV, and no symptoms is often just aging physiology rather than deficiency. Because ferritin is an acute-phase reactant, some clinical groups use a higher ferritin threshold to call deficiency in older adults than the threshold used in younger people, precisely because low-grade chronic inflammation is common at older ages and can push ferritin above a young adult's cutoff without reflecting adequate iron stores.
New iron-deficiency anemia discovered after age 60 is treated differently from the same lab pattern in a 25-year-old: the priority shifts from correcting the anemia to finding the source of blood loss, most often gastrointestinal. Iron-deficiency anemia in an older adult is a widely accepted indication for gastrointestinal evaluation, generally colonoscopy, independent of routine colorectal cancer screening intervals. The US Preventive Services Task Force's colorectal cancer screening recommendation addresses population screening in asymptomatic adults and does not itself set the threshold for working up unexplained anemia; the two are related but distinct clinical decisions (USPSTF, Colorectal Cancer: Screening).
Oral iron absorption tends to decline with age, reduced stomach acid, and concurrent proton pump inhibitor use, which is part of why intravenous iron is used more often in older adults with malabsorption or intolerance. Specific comparative response rates between oral and intravenous iron vary by formulation and population studied; a precise head-to-head percentage should not be cited without checking the specific trial and its inclusion criteria.
The oldest adults (80 and above)
Anemia is common in this age group and is frequently multifactorial, combining chronic disease, reduced kidney function, marginal nutrition, and sometimes unrecognized iron deficiency. A ferritin that falls within a lab's printed "normal" range can still represent functional iron deficiency in an older adult with ongoing inflammation, which is why CRP should generally accompany any iron panel ordered in this age group.
Undiagnosed hereditary hemochromatosis can also present for the first time in the eighth or ninth decade, usually because it was missed earlier or because organ damage was attributed to other causes. Phlebotomy remains the standard treatment for confirmed iron overload at any age, though the pace of treatment in older adults is generally more conservative to avoid cardiovascular strain from rapid volume shifts.
What is established, what is plausible, and what is not established
Established: TSAT below roughly 16 to 20% combined with a low ferritin and a high TIBC is a reliable pattern for iron deficiency. TSAT persistently above roughly 45% combined with an elevated ferritin is a recognized trigger for HFE genetic testing in guideline-based hemochromatosis screening. Menstruating women and growing children have materially higher iron requirements than adult men, which is reflected in the NIH's dietary allowance figures. Anemia discovered for the first time in an older adult warrants a search for a bleeding source rather than reflexive iron replacement.
Plausible but not settled: That a TSAT in the 25 to 40% range confers a meaningful health advantage over a TSAT at the low end of the standard reference range in an asymptomatic person is a hypothesis discussed in some clinical circles, not an established treatment target endorsed by a major guideline body. Associations between high-normal or elevated TSAT and cardiovascular risk have been reported in observational research, but observational association does not establish that lowering TSAT in an otherwise healthy person reduces cardiovascular events.
Not established on the evidence available here: Precise numeric estimates for condition prevalence by age and sex subgroup (for example, the exact percentage of toddlers or teenage girls with iron deficiency in a given country and year), and precise comparative efficacy figures for specific supplementation regimens or intravenous iron formulations, require verification against the specific primary study before they are repeated as fact. This draft intentionally does not carry forward numeric citations that could not be verified against a specific, checkable source.
A practical framework: TIBC as the tiebreaker
When TSAT is low, TIBC tells you whether to think "iron deficiency" or "inflammation," and that distinction changes what happens next far more than the TSAT number alone does.
| TSAT | TIBC | Ferritin | CRP | Most likely pattern | Reasonable next step |
|---|---|---|---|---|---|
| Low (below ~20%) | High (above ~370 mcg/dL) | Low | Normal | True iron deficiency | Identify the cause (diet, menstrual loss, GI bleeding depending on age); consider supplementation |
| Low | Low or low-normal (below ~250 mcg/dL) | Normal or high | Elevated | Anemia of inflammation/chronic disease, not iron deficiency | Address the underlying inflammatory condition; oral iron is unlikely to help on its own |
| Low | Normal | Low-normal | Elevated | Mixed picture: possible true deficiency masked by inflammation | Consider soluble transferrin receptor testing; retest after the inflammatory episode resolves |
| High (above ~45%) | Low | High | Normal | Possible iron overload or hereditary hemochromatosis | Repeat fasting panel; if confirmed, HFE genetic testing before starting treatment |
| High | Normal | Normal | Normal | Non-fasting draw, recent meal, or transient hepatic release | Repeat as a fasting morning draw before concluding overload |
| Normal | Normal | Normal | Normal, but symptoms persist | Functional iron deficiency less likely to show on standard panel | Discuss soluble transferrin receptor or reassess for a non-iron cause of symptoms |
Use this table as a basis for discussing iron metabolism and iron studies with your clinician rather than as a replacement for clinical judgment. The patterns shown here may be altered by pregnancy, recent blood transfusion, ongoing hemorrhage, or coexisting hepatic disease.
When urgent evaluation is appropriate
New, unexplained anemia with a low iron panel in an adult over 50, especially with symptoms such as rectal bleeding, black stools, unintended weight loss, or new abdominal pain, warrants prompt medical evaluation rather than a trial of over-the-counter iron. A persistently elevated fasting TSAT above roughly 45% with an elevated ferritin, particularly with a family history of liver disease, diabetes, or early heart failure, warrants a conversation with a clinician about HFE testing rather than self-directed dietary changes.
Common reader questions
Frequently asked questions
What is a normal transferrin saturation?
What does a high TIBC mean?
What does a low TIBC mean?
Can transferrin saturation be high without hemochromatosis?
Should I start iron supplements if my TSAT is around 18 percent?
How does pregnancy change how the iron panel should be read?
Why does an older adult need a colonoscopy for iron deficiency anemia if they are not due for cancer screening?
References
- NIH Office of Dietary Supplements. Iron Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/
- Centers for Disease Control and Prevention. Recommendations to Prevent and Control Iron Deficiency in the United States, MMWR, 1998. https://www.cdc.gov/mmwr/preview/mmwrhtml/00051880.htm
- US Preventive Services Task Force. Colorectal Cancer: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
A note for the editorial team: the prior draft of this page carried numerous specific study citations (PMIDs), percentages, sample sizes, and one long quotation attributed to a named guideline. None of those identifiers could be verified against the primary literature during this revision, and several appeared to be mismatched or fabricated. They have been removed or rewritten as general, unattributed statements. Any decade-specific prevalence figure, comparative treatment efficacy number, or guideline quotation that is reinstated for publication should be checked against the actual primary source (PubMed, the relevant society's current guideline page, or the original trial) before it goes live.